173 related articles for article (PubMed ID: 24635044)
1. CD84 is markedly up-regulated in Kawasaki disease arteriopathy.
Reindel R; Bischof J; Kim KY; Orenstein JM; Soares MB; Baker SC; Shulman ST; Perlman EJ; Lingen MW; Pink AJ; Trevenen C; Rowley AH
Clin Exp Immunol; 2014 Jul; 177(1):203-11. PubMed ID: 24635044
[TBL] [Abstract][Full Text] [Related]
2. Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis.
Rowley AH; Baker SC; Kim KA; Shulman ST; Yang A; Arrollo D; DeBerge M; Han S; Sibinga NES; Pink AJ; Thorp EB
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e94-e102. PubMed ID: 28505365
[TBL] [Abstract][Full Text] [Related]
3. Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.
Cameron SA; White SM; Arrollo D; Shulman ST; Rowley AH
Clin Exp Immunol; 2017 Nov; 190(2):244-250. PubMed ID: 28707750
[TBL] [Abstract][Full Text] [Related]
4. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
[TBL] [Abstract][Full Text] [Related]
6. Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.
Ebata R; Abe J; Yasukawa K; Hamada H; Higashi K; Suwazono Y; Saito H; Terai M; Kohno Y
Circ J; 2011; 75(6):1455-62. PubMed ID: 21483160
[TBL] [Abstract][Full Text] [Related]
7. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
Fury W; Tremoulet AH; Watson VE; Best BM; Shimizu C; Hamilton J; Kanegaye JT; Wei Y; Kao C; Mellis S; Lin C; Burns JC
Hum Immunol; 2010 Sep; 71(9):865-73. PubMed ID: 20600450
[TBL] [Abstract][Full Text] [Related]
8. [The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yuan XW
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):333-6. PubMed ID: 16780707
[TBL] [Abstract][Full Text] [Related]
9. Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study.
Nomura I; Abe J; Noma S; Saito H; Gao B; Wheeler G; Leung DY
Pediatr Res; 2005 Jan; 57(1):49-55. PubMed ID: 15531734
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium.
Freeman AF; Crawford SE; Cornwall ML; Garcia FL; Shulman ST; Rowley AH
Pediatr Cardiol; 2005; 26(5):578-84. PubMed ID: 16132289
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis.
Hofmann S; Braun A; Pozgaj R; Morowski M; Vögtle T; Nieswandt B
PLoS One; 2014; 9(12):e115306. PubMed ID: 25551754
[TBL] [Abstract][Full Text] [Related]
12. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
Zhang J; Gui YH; Yang Y
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetics of Kawasaki disease.
Kumrah R; Vignesh P; Rawat A; Singh S
Clin Rev Allergy Immunol; 2020 Aug; 59(1):122-139. PubMed ID: 32200494
[TBL] [Abstract][Full Text] [Related]
14. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.
Ikeda K; Yamaguchi K; Tanaka T; Mizuno Y; Hijikata A; Ohara O; Takada H; Kusuhara K; Hara T
Clin Exp Immunol; 2010 May; 160(2):246-55. PubMed ID: 20015095
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease.
Rowley AH; Shulman ST; Spike BT; Mask CA; Baker SC
J Immunol; 2001 Jan; 166(2):1334-43. PubMed ID: 11145718
[TBL] [Abstract][Full Text] [Related]
16. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
17. Gene-expression patterns reveal underlying biological processes in Kawasaki disease.
Popper SJ; Shimizu C; Shike H; Kanegaye JT; Newburger JW; Sundel RP; Brown PO; Burns JC; Relman DA
Genome Biol; 2007; 8(12):R261. PubMed ID: 18067656
[TBL] [Abstract][Full Text] [Related]
18. Transient thrombocytopenia with large platelets in Kawasaki disease.
Asano T; Sudoh M; Watanabe M; Fujino O
Pediatr Hematol Oncol; 2007; 24(7):551-4. PubMed ID: 17786792
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
20. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
Ueno K; Nomura Y; Morita Y; Eguchi T; Masuda K; Kawano Y
Circ J; 2015; 79(6):1349-56. PubMed ID: 25787672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
